148 related articles for article (PubMed ID: 27989146)
1. Different Reactive Metabolites of Nevirapine Require Distinct Glutathione S-Transferase Isoforms for Bioinactivation.
Dekker SJ; Zhang Y; Vos JC; Vermeulen NP; Commandeur JN
Chem Res Toxicol; 2016 Dec; 29(12):2136-2144. PubMed ID: 27989146
[TBL] [Abstract][Full Text] [Related]
2. Metabolic activation of nevirapine in human liver microsomes: dehydrogenation and inactivation of cytochrome P450 3A4.
Wen B; Chen Y; Fitch WL
Drug Metab Dispos; 2009 Jul; 37(7):1557-62. PubMed ID: 19364830
[TBL] [Abstract][Full Text] [Related]
3. Role of human glutathione S-transferases in the inactivation of reactive metabolites of clozapine.
Dragovic S; Boerma JS; van Bergen L; Vermeulen NP; Commandeur JN
Chem Res Toxicol; 2010 Sep; 23(9):1467-76. PubMed ID: 20849150
[TBL] [Abstract][Full Text] [Related]
4. Involvement of different human glutathione transferase isoforms in the glutathione conjugation of reactive metabolites of troglitazone.
Okada R; Maeda K; Nishiyama T; Aoyama S; Tozuka Z; Hiratsuka A; Ikeda T; Kusuhara H; Sugiyama Y
Drug Metab Dispos; 2011 Dec; 39(12):2290-7. PubMed ID: 21914835
[TBL] [Abstract][Full Text] [Related]
5. Simulation of interindividual differences in inactivation of reactive para-benzoquinone imine metabolites of diclofenac by glutathione S-transferases in human liver cytosol.
den Braver MW; Zhang Y; Venkataraman H; Vermeulen NP; Commandeur JN
Toxicol Lett; 2016 Jul; 255():52-62. PubMed ID: 27183920
[TBL] [Abstract][Full Text] [Related]
6. Human glutathione S-transferases- and NAD(P)H:quinone oxidoreductase 1-catalyzed inactivation of reactive quinoneimines of amodiaquine and N-desethylamodiaquine: Possible implications for susceptibility to amodiaquine-induced liver toxicity.
Zhang Y; den Braver-Sewradj SP; Vos JC; Vermeulen NPE; Commandeur JNM
Toxicol Lett; 2017 Jun; 275():83-91. PubMed ID: 28478157
[TBL] [Abstract][Full Text] [Related]
7. Amino acid adduct formation by the nevirapine metabolite, 12-hydroxynevirapine--a possible factor in nevirapine toxicity.
Antunes AM; Godinho AL; Martins IL; Justino GC; Beland FA; Marques MM
Chem Res Toxicol; 2010 May; 23(5):888-99. PubMed ID: 20392079
[TBL] [Abstract][Full Text] [Related]
8. Cytochrome P450-mediated bioactivation of mefenamic acid to quinoneimine intermediates and inactivation by human glutathione S-transferases.
Venkataraman H; den Braver MW; Vermeulen NP; Commandeur JN
Chem Res Toxicol; 2014 Dec; 27(12):2071-81. PubMed ID: 25372302
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of nevirapine analogs to study the metabolic activation of nevirapine.
Tateishi Y; Ohe T; Yasuda D; Takahashi K; Nakamura S; Kazuki Y; Mashino T
Drug Metab Pharmacokinet; 2020 Apr; 35(2):238-243. PubMed ID: 32184040
[TBL] [Abstract][Full Text] [Related]
10. Nevirapine bioactivation and covalent binding in the skin.
Sharma AM; Klarskov K; Uetrecht J
Chem Res Toxicol; 2013 Mar; 26(3):410-21. PubMed ID: 23387501
[TBL] [Abstract][Full Text] [Related]
11. Effect of human glutathione S-transferases on glutathione-dependent inactivation of cytochrome P450-dependent reactive intermediates of diclofenac.
Dragovic S; Boerma JS; Vermeulen NP; Commandeur JN
Chem Res Toxicol; 2013 Nov; 26(11):1632-41. PubMed ID: 24083800
[TBL] [Abstract][Full Text] [Related]
12. One-electron oxidation of diclofenac by human cytochrome P450s as a potential bioactivation mechanism for formation of 2'-(glutathion-S-yl)-deschloro-diclofenac.
Boerma JS; Vermeulen NP; Commandeur JN
Chem Biol Interact; 2014 Jan; 207():32-40. PubMed ID: 24246759
[TBL] [Abstract][Full Text] [Related]
13. Quantifying the metabolic activation of nevirapine in patients by integrated applications of NMR and mass spectrometries.
Srivastava A; Lian LY; Maggs JL; Chaponda M; Pirmohamed M; Williams DP; Park BK
Drug Metab Dispos; 2010 Jan; 38(1):122-32. PubMed ID: 19797610
[TBL] [Abstract][Full Text] [Related]
14. Bioactivation of phencyclidine in rat and human liver microsomes and recombinant P450 2B enzymes: evidence for the formation of a novel quinone methide intermediate.
Driscoll JP; Kornecki K; Wolkowski JP; Chupak L; Kalgutkar AS; O'Donnell JP
Chem Res Toxicol; 2007 Oct; 20(10):1488-97. PubMed ID: 17892269
[TBL] [Abstract][Full Text] [Related]
15. Protein adducts as prospective biomarkers of nevirapine toxicity.
Antunes AM; Godinho AL; Martins IL; Oliveira MC; Gomes RA; Coelho AV; Beland FA; Marques MM
Chem Res Toxicol; 2010 Nov; 23(11):1714-25. PubMed ID: 20809596
[TBL] [Abstract][Full Text] [Related]
16. Singularities of nevirapine metabolism: from sex-dependent differences to idiosyncratic toxicity.
Marinho AT; Miranda JP; Caixas U; Charneira C; Gonçalves-Dias C; Marques MM; Monteiro EC; Antunes AMM; Pereira SA
Drug Metab Rev; 2019 Feb; 51(1):76-90. PubMed ID: 30712401
[TBL] [Abstract][Full Text] [Related]
17. Role of glutathione S-transferases A1-1, M1-1, and P1-1 in the detoxification of 2-phenylpropenal, a reactive felbamate metabolite.
Dieckhaus CM; Roller SG; Santos WL; Sofia RD; Macdonald TL
Chem Res Toxicol; 2001 May; 14(5):511-6. PubMed ID: 11368548
[TBL] [Abstract][Full Text] [Related]
18. Demonstration of the metabolic pathway responsible for nevirapine-induced skin rash.
Chen J; Mannargudi BM; Xu L; Uetrecht J
Chem Res Toxicol; 2008 Sep; 21(9):1862-70. PubMed ID: 18729332
[TBL] [Abstract][Full Text] [Related]
19. 2-ABT-S-oxide detoxification by glutathione S-transferases A1-1, M1-1 and P1-1: implications for toxicity associated with zileuton.
Joshi EM; Heasley BH; Macdonald TL
Xenobiotica; 2009 Mar; 39(3):197-204. PubMed ID: 19280518
[TBL] [Abstract][Full Text] [Related]
20. Glutathione S-transferase-catalyzed conjugation of bioactivated aflatoxin B(1) in human lung: differential cellular distribution and lack of significance of the GSTM1 genetic polymorphism.
Stewart RK; Smith GB; Donnelly PJ; Reid KR; Petsikas D; Conlan AA; Massey TE
Carcinogenesis; 1999 Oct; 20(10):1971-7. PubMed ID: 10506113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
